Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulation

This publication has 34 references indexed in Scilit:

• Causes of Alternative Pathway Dysregulation in Dense Deposit Disease
  Clinical Journal of the American Society of Nephrology, 2012
• Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk
  Proceedings of the National Academy of Sciences, 2011
• The disease-protective complement factor H allotypic variant Ile62 shows increased binding affinity for C3b and enhanced cofactor activity
  Human Molecular Genetics, 2009
• Harmful molecular mechanisms in sepsis
  Nature Reviews Immunology, 2008
• Translational Mini-Review Series on Complement Factor H: Renal diseases associated with complement factor H: novel insights from humans and animals
  Clinical and Experimental Immunology, 2008
• Molecular Dissection of Interactions between Components of the Alternative Pathway of Complement and Decay Accelerating Factor (CD55)
  Journal of Biological Chemistry, 2005
• Clinical Features and Metabolic and Autoimmune Derangements in Acquired Partial Lipodystrophy
  Medicine, 2004
• Coupling complement regulators to immunoglobulin domains generates effective anti-complement reagents with extended half-lifein vivo
  Clinical and Experimental Immunology, 2002
• On the origin of C3 nephritic factor (antibody to the alternative pathway C3 convertase): Evidence for the Adam and Eve concept of autoantibody production
  Clinical Immunology and Immunopathology, 1992
• Two types of C3 nephritic factor: Properdin-dependent C3NeF and properdin-independent C3NeF
  Clinical Immunology and Immunopathology, 1990